GENOMICS OF APOPTOSIS & ANGIOGENESIS IN ISLET CARCINOMA
GENOMICS OF APOPTOSIS & ANGIOGENESIS IN ISLET CARCINOMA
批准号:
2896602
负责人:
DOUGLAS HANAHAN
金额:
$41.3万
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-08-06 至 2003-05-31
关键词:
angiogenesis apoptosis carcinogenesis cell line chromosome deletion embryo /fetus cell /tissue gene expression gene targeting genetic mapping genetic models genetically modified animals human tissue laboratory mouse loss of heterozygosity molecular cloning neoplasm /cancer genetics pancreatic islet neoplasm regulatory gene tumor suppressor genes
中文摘要
癌症的转基因小鼠模型呈现出一系列实验性
机会,包括阐明肿瘤发展的途径
和进步。 与人类癌症一样,在小鼠
肿瘤的发生有可能是有指导意义的机制,
导致癌症的潜在途径 在过去的十年里,
胰岛细胞癌模型已被证明是一个有价值的原型,
研究多阶段肿瘤发生的参数。 具体变化
包括杂合性/DNA拷贝数特征性丢失,
染色体9(命名为LOH9)和16(LOH16),获得
抗凋亡和诱导血管生成。 这些
观察导致LOH9编码细胞凋亡的假设,
LOH16编码血管生成抑制基因。 这
该项目汇集了哈纳汉实验室的互补人才,
拥有转基因小鼠模型及其
和格雷实验室,他们在癌症方面有专业知识,
遗传学和表征癌细胞基因组的技术。
这些实验将一起精确地确定最小程度的
LOH9和LOH16,检验细胞凋亡和血管生成是
部分由这些区域的肿瘤抑制基因控制,
鉴定所涉及的基因,分别命名为loh 9和loh 16。
在这样做的过程中,该项目将阐明
肿瘤发生在这个模型中,并有助于发展和完善
这些技术策略应该被证明广泛适用于鼠标
癌症模型。 具体而言,该项目将:
筛选技术来检测和精细结构映射这些肿瘤
利用多重洛缺失和基于阵列的CGH的抑制基因座,和
在对一个银行的分析过程中,
大约450例胰岛癌;评估LOH 9的假设
LOH16编码一个凋亡调节基因,
抑制血管生成,使用体外和体内生物测定,
结合基因组分析、功能选择和遗传学
通过BAC DNA转移进行互补;
功能互补和/或定位克隆技术,和
开始分析它们在胰岛癌中的表达及作用
途径,以及人类癌症。
英文摘要
Transgenic mouse models of cancer present a spectrum of experimental
opportunities, including elucidation of pathways of tumor development
and progression. As in human cancers, genetic changes during mouse
tumorigenesis have the potential to be instructive about mechanisms
underlying pathways to cancer. Over the last decade the RIP-Tag mouse
model of islet cell carcinoma has proved a valuable prototype for
investigating parameters of multistage tumorigenesis. Specific changes
include characteristic losses of heterozygosity/DNA copy number on
chromosomes 9 (designated LOH9) and 16 (LOH16), acquisition of
resistance to apoptosis, and induction of angiogenesis. These
observations have lead to the hypothesis that LOH9 encodes an apoptosis
regulatory gene and LOH16 encodes an angiogenesis suppressor gene. This
project brings together complementary talents of the Hanahan lab, which
has expertise and experience in transgenic mouse models and their
characterization, and the Gray lab, which has expertise in cancer
genetics and in technologies for characterizing cancer cell genomes.
Together these labs shall precisely determine the minimal extents of
LOH9 and LOH16, test the hypothesis that apoptosis and angiogenesis are
partly controlled by tumor suppressor genes in these regions and
identify the involved genes, designated loh9 and loh16; respectively.
In so doing, this project will shed light on the mechanism of
tumorigenesis in this model, and serve to develop and refine
technological strategies that should prove broadly applicable to mouse
models of cancer. Specifically, this project will: Develop genome
screening technologies to detect and fine structure map these tumor
suppressor loci utilizing multiplex LOH and array-based CGH, and
rigorously compare these techniques during the analysis of a bank of
approximately 450 islet carcinomas; Assess the hypotheses that LOH9
encodes an apoptosis regulatory gene and that LOH16 encodes a gene that
suppresses angiogenesis, using in vitro and in vivo bioassays in
conjunction with genomic analysis, functional selection, and genetic
complementation via BAC DNA transfer; Isolate loh9 and loh16 using
functional complementation and/or positional cloning techniques, and
begin to analyze their expression and roles in the islet carcinoma
pathway, and in human cancers.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Functions in tumors of recurrently amplified Prefoldin-4
-
批准号:7413586
-
项目类别:
-
资助金额:$28.37万
-
财政年份:2005
-
负责人:DOUGLAS HANAHAN
-
依托单位:
Functions in tumors of recurrently amplified Prefoldin-4
-
批准号:7228976
-
项目类别:
-
资助金额:$28.37万
-
财政年份:2005
-
负责人:DOUGLAS HANAHAN
-
依托单位:
Detecting cancer early with targeted nano-probes for vascular signatures
-
批准号:7500071
-
项目类别:
-
资助金额:$60.95万
-
财政年份:2005
-
负责人:DOUGLAS HANAHAN
-
依托单位:
Functions in tumors of recurrently amplified Prefoldin-4
-
批准号:6970170
-
项目类别:
-
资助金额:$29.92万
-
财政年份:2005
-
负责人:DOUGLAS HANAHAN
-
依托单位:
Functions in tumors of recurrently amplified Prefoldin-4
-
批准号:7610941
-
项目类别:
-
资助金额:$28.37万
-
财政年份:2005
-
负责人:DOUGLAS HANAHAN
-
依托单位:
Mechanisms & Therapeutic Targeting of the Microenvironment in Pancreatic Cancer
-
批准号:7037884
-
项目类别:
-
资助金额:$25.94万
-
财政年份:2005
-
负责人:DOUGLAS HANAHAN
-
依托单位:
Detecting cancer early with targeted nano-probes for vascular signatures
-
批准号:7288295
-
项目类别:
-
资助金额:$61.52万
-
财政年份:2005
-
负责人:DOUGLAS HANAHAN
-
依托单位:
Functions in tumors of recurrently amplified Prefoldin-4
-
批准号:7100254
-
项目类别:
-
资助金额:$29.22万
-
财政年份:2005
-
负责人:DOUGLAS HANAHAN
-
依托单位:
Detecting cancer early with targeted nano-probes
-
批准号:7050966
-
项目类别:
-
资助金额:$65.0万
-
财政年份:2005
-
负责人:DOUGLAS HANAHAN
-
依托单位:
Detecting cancer early with targeted nano-probes for va*
-
批准号:7127733
-
项目类别:
-
资助金额:$62.66万
-
财政年份:2005
-
负责人:DOUGLAS HANAHAN
-
依托单位:
Detecting cancer early with targeted nano-probes for vascular signatures
-
批准号:7669282
-
项目类别:
-
资助金额:$61.59万
-
财政年份:2005
-
负责人:DOUGLAS HANAHAN
-
依托单位:
Immune Enhancement and Therapy of Cancer
-
批准号:6949087
-
项目类别:
-
资助金额:$63.06万
-
财政年份:2004
-
负责人:DOUGLAS HANAHAN
-
依托单位:
Immune Enhancement and Therapy of Cancer
-
批准号:7076925
-
项目类别:
-
资助金额:$66.07万
-
财政年份:2004
-
负责人:DOUGLAS HANAHAN
-
依托单位:
Immune Enhancement and Therapy of Cancer
-
批准号:6729791
-
项目类别:
-
资助金额:$54.22万
-
财政年份:2004
-
负责人:DOUGLAS HANAHAN
-
依托单位:
Immune Enhancement and Therapy of Cancer
-
批准号:7415200
-
项目类别:
-
资助金额:$50.09万
-
财政年份:2004
-
负责人:DOUGLAS HANAHAN
-
依托单位:
Immune Enhancement and Therapy of Cancer
-
批准号:7267812
-
项目类别:
-
资助金额:$59.86万
-
财政年份:2004
-
负责人:DOUGLAS HANAHAN
-
依托单位:
Stage- & cell-specific targeting of RTK in tumorigenesis
-
批准号:7175305
-
项目类别:
-
资助金额:$50.38万
-
财政年份:2003
-
负责人:DOUGLAS HANAHAN
-
依托单位:
Stage- & cell-specific targeting of RTK in tumorigenesis
-
批准号:6593547
-
项目类别:
-
资助金额:$48.33万
-
财政年份:2003
-
负责人:DOUGLAS HANAHAN
-
依托单位:
Stage- & cell-specific targeting of RTK in tumorigenesis
-
批准号:6858827
-
项目类别:
-
资助金额:$50.08万
-
财政年份:2003
-
负责人:DOUGLAS HANAHAN
-
依托单位:
Stage- & cell-specific targeting of RTK in tumorigenesis
-
批准号:6703095
-
项目类别:
-
资助金额:$48.62万
-
财政年份:2003
-
负责人:DOUGLAS HANAHAN
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位:
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
-
批准号:39500043
-
项目类别:青年科学基金项目
-
资助金额:9.0万元
-
批准年份:1995
-
负责人:梁克
-
依托单位: